AFC-HD AMS Life Science Co.,Ltd. [2927.T]
TOKYO, Apr 14 (Pulse News Wire) – Afc-hd AMS Life Science CO.,LTD. (2927.T) raised its fiscal year 2026 forecast, ending August 31, 2026.
The revised outlook shows an increase in net profit attributable to parent shareholders by 83 million yen compared to the previous estimate, marking a 5.7% rise. The revision comes due to higher deferred tax assets from subsidiaries, which positively impacts the net profit through tax effect accounting. As a result, the company now expects to exceed its previously stated projections.
In the updated forecast, operating revenue remains unchanged at ¥34.14 billion, while operating profit and ordinary profit also stay consistent at ¥2.545 billion and ¥2.445 billion respectively. The earnings per share are expected to grow to ¥106.1 million, up from the prior projection. For comparison, the company reported revenues of ¥32.66 billion and net profits of ¥1.448 billion in the fiscal year ended August 31, 2025.
🟢 Confidence: High AI-translated content.